16 September 2026 editorial review · Item
Tandem Mobi (Control-IQ+): review notes
These notes document the scope actually reviewed, including source-access limits. They are not independent clinical certification or a guarantee that every claim was verified.
Read the item evidence page →Thriving evidence review — 16 September 2026
Record: Tandem Mobi (Control-IQ+)
Scope and findings:
- Read current Mobi system specifications and three open FDA correction records; preserved software-specific risk and compatibility distinctions. Foundational Control-IQ outcomes are not a randomized evaluation of Mobi hardware.
Primary sources checked:
Limits: The review is restricted to the scopes above. Historical efficacy estimates, editorial scoring and country-specific access were not fully reverified unless expressly stated. A manufacturer or conference report retains that evidence level.